Wall Street brokerages expect National Health Investors Inc (NYSE:NHI) to post $71.36 million in sales for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for National Health Investors’ earnings. The highest sales estimate is $71.83 million and the lowest is $70.90 million. National Health Investors posted sales of $64.69 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 10.3%. The business is expected to announce its next quarterly earnings results on Friday, February 16th.
On average, analysts expect that National Health Investors will report full-year sales of $71.36 million for the current year, with estimates ranging from $275.00 million to $279.03 million. For the next financial year, analysts expect that the company will post sales of $300.42 million per share, with estimates ranging from $298.19 million to $303.08 million. Zacks’ sales calculations are a mean average based on a survey of analysts that cover National Health Investors.
National Health Investors (NYSE:NHI) last announced its earnings results on Wednesday, November 8th. The real estate investment trust reported $0.94 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.34 by ($0.40). National Health Investors had a return on equity of 12.74% and a net margin of 59.70%.
Several institutional investors and hedge funds have recently bought and sold shares of NHI. BlackRock Inc. boosted its position in shares of National Health Investors by 6.6% in the second quarter. BlackRock Inc. now owns 3,547,049 shares of the real estate investment trust’s stock valued at $280,927,000 after acquiring an additional 218,482 shares during the period. Allianz Asset Management GmbH boosted its position in shares of National Health Investors by 57.8% in the third quarter. Allianz Asset Management GmbH now owns 394,800 shares of the real estate investment trust’s stock valued at $30,514,000 after acquiring an additional 144,650 shares during the period. State Street Corp boosted its position in shares of National Health Investors by 8.5% in the second quarter. State Street Corp now owns 999,167 shares of the real estate investment trust’s stock valued at $79,133,000 after acquiring an additional 78,355 shares during the period. Vanguard Group Inc. boosted its position in shares of National Health Investors by 1.2% in the second quarter. Vanguard Group Inc. now owns 6,291,954 shares of the real estate investment trust’s stock valued at $498,323,000 after acquiring an additional 72,518 shares during the period. Finally, Employees Retirement System of Texas boosted its position in shares of National Health Investors by 353.3% in the second quarter. Employees Retirement System of Texas now owns 81,600 shares of the real estate investment trust’s stock valued at $6,463,000 after acquiring an additional 63,600 shares during the period. 70.12% of the stock is owned by institutional investors.
Shares of National Health Investors (NYSE:NHI) opened at $69.80 on Monday. The stock has a market capitalization of $2,898.94, a P/E ratio of 17.45, a price-to-earnings-growth ratio of 3.22 and a beta of 0.59. The company has a current ratio of 12.72, a quick ratio of 12.72 and a debt-to-equity ratio of 0.84. National Health Investors has a 12-month low of $68.96 and a 12-month high of $81.60.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 31st. Stockholders of record on Friday, December 29th will be given a $0.95 dividend. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $3.80 annualized dividend and a dividend yield of 5.44%. National Health Investors’s dividend payout ratio is 95.00%.
National Health Investors Company Profile
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.